Global computing firm IBM and California, USA-based contract manufacturer and logistics provider Golden State Medical Supply have partnered to help drugmakers comply with prescription drug pedigree regulations ahead of Californian legislation that has been postponed to 2015. The biggest US state has pioneered rules to protect against counterfeit drugs which are also being considered in other jurisdictions (Marketletters passim).
The WebSphere Premises Server software overcomes many of the previous obstacles to electronic pedigree programs faced by small- to mid-size pharmaceutical companies, IBM claims. "New improvements in technology, lower costs, as well as new industry standards for sharing and analyzing information are making it possible for drug companies of any size to ensure their drugs are authentic - while enabling the use of smart technology to track movement of drugs from the manufacturing floor to the pharmacy," the firm said.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze